Phase II Study of Postoperative Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESO- Shanghai 17)
Status:
Recruiting
Trial end date:
2027-03-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate safety and 2-year local control rate for
postoperative concurrent chemoradiotherapy for esophageal squamous cell carcinoma.